Market Closed -
Nyse
01:30:02 01/05/2024 am IST
|
5-day change
|
1st Jan Change
|
7
USD
|
-1.55%
|
|
-3.85%
|
+52.17%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,437
|
702.8
|
1,017
|
-
|
-
|
Enterprise Value (EV)
1 |
2,080
|
1,436
|
1,675
|
1,616
|
1,554
|
P/E ratio
|
17.6
x
|
11.2
x
|
33
x
|
28.8
x
|
34.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.99
x
|
2.18
x
|
2.24
x
|
2.09
x
|
1.98
x
|
EV / Revenue
|
5.77
x
|
4.46
x
|
3.69
x
|
3.32
x
|
3.02
x
|
EV / EBITDA
|
16.6
x
|
14.8
x
|
9.89
x
|
8.64
x
|
7.81
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.26
x
|
0.58
x
|
0.86
x
|
0.82
x
|
0.78
x
|
Nbr of stocks (in thousands)
|
1,57,261
|
1,52,784
|
1,45,240
|
-
|
-
|
Reference price
2 |
9.140
|
4.600
|
7.000
|
7.000
|
7.000
|
Announcement Date
|
28/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
360.5
|
322.1
|
453.5
|
486.3
|
514.5
|
EBITDA
1 |
125.4
|
96.79
|
169.3
|
187.1
|
198.9
|
EBIT
1 |
59.6
|
31.93
|
99.39
|
116.8
|
128.4
|
Operating Margin
|
16.53%
|
9.91%
|
21.91%
|
24.01%
|
24.95%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.5200
|
0.4100
|
0.2124
|
0.2434
|
0.2023
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
57.76
|
101
|
160.5
|
41.27
|
43.86
|
76.14
|
142.7
|
59.46
|
50.66
|
104.5
|
215.1
|
74.37
|
47.9
|
EBITDA
1 |
11.98
|
35.68
|
75.63
|
2.105
|
3.116
|
20.99
|
61.47
|
11.21
|
6.346
|
39.53
|
108.3
|
10.88
|
5.172
|
EBIT
1 |
-19.25
|
18.97
|
59.18
|
-14.15
|
-12.97
|
4.86
|
45.19
|
-5.15
|
-10
|
22.48
|
91.48
|
-5.817
|
-11.34
|
Operating Margin
|
-33.33%
|
18.79%
|
36.87%
|
-34.29%
|
-29.57%
|
6.38%
|
31.68%
|
-8.66%
|
-19.75%
|
21.52%
|
42.54%
|
-7.82%
|
-23.67%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.2200
|
0.0400
|
0.4500
|
-0.1900
|
0.0600
|
0.3100
|
0.1200
|
-0.0900
|
-0.1898
|
0.0696
|
0.4373
|
-0.1011
|
-0.2508
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
09/05/22
|
05/08/22
|
04/11/22
|
28/02/23
|
10/05/23
|
03/08/23
|
09/11/23
|
22/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
643
|
733
|
658
|
599
|
538
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.128
x
|
7.577
x
|
3.889
x
|
3.204
x
|
2.703
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
8.26%
|
-0.31%
|
3.74%
|
4.77%
|
4.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
7.260
|
7.870
|
8.170
|
8.550
|
8.920
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
8.61
|
9.44
|
14
|
15
|
15
|
Capex / Sales
|
2.39%
|
2.93%
|
3.09%
|
3.08%
|
2.92%
|
Announcement Date
|
28/02/23
|
22/02/24
|
-
|
-
|
-
|
Average target price
10
USD Spread / Average Target +42.86% Consensus |
1st Jan change
|
Capi.
|
---|
| +52.17% | 1.02B | | +14.02% | 64.66B | | -3.80% | 46.08B | | +13.26% | 39.72B | | +19.28% | 25.82B | | +8.22% | 18.8B | | -1.13% | 17.14B | | -21.03% | 15.86B | | +1.06% | 15.05B | | -16.73% | 14.14B |
Other Specialty Chemicals
|